Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery.

Martinussen C, Veedfald S, Dirksen C, Bojsen-Møller KN, Svane MS, Wewer Albrechtsen NJ, van Hall G, Kristiansen VB, Fenger M, Holst JJ, Madsbad S.

Am J Physiol Endocrinol Metab. 2020 Mar 17. doi: 10.1152/ajpendo.00023.2020. [Epub ahead of print]

PMID:
32182123
2.

Responses of gut and pancreatic hormones, bile acids, and fibroblast growth factor-21 differ to glucose, protein, and fat ingestion after gastric bypass surgery.

Jensen CZ, Bojsen-Møller KN, Svane MS, Holst LM, Hermansen K, Hartmann B, Wewer Albrechtsen NJ, Kuhre RE, Kristiansen VB, Rehfeld JF, Clausen TR, Holst JJ, Madsbad S.

Am J Physiol Gastrointest Liver Physiol. 2020 Apr 1;318(4):G661-G672. doi: 10.1152/ajpgi.00265.2019. Epub 2020 Feb 18.

PMID:
32068442
3.

Intestinal sensing and handling of dietary lipids in gastric bypass-operated patients and matched controls.

Martinussen C, Dirksen C, Bojsen-Møller KN, Svane MS, Carlsson ER, Hartmann B, Clausen TR, Veedfald S, Kristiansen VB, Rehfeld JF, Hansen HS, Holst JJ, Madsbad S.

Am J Clin Nutr. 2020 Jan 1;111(1):28-41. doi: 10.1093/ajcn/nqz272.

PMID:
31742316
4.

Sustained Improvements in Glucose Metabolism Late After Roux-En-Y Gastric Bypass Surgery in Patients with and Without Preoperative Diabetes.

Jørgensen NB, Bojsen-Møller KN, Dirksen C, Martinussen C, Svane MS, Kristiansen VB, Holst JJ, Madsbad S.

Sci Rep. 2019 Oct 22;9(1):15154. doi: 10.1038/s41598-019-51516-y.

5.

GLP-2 and GIP exert separate effects on bone turnover: A randomized, placebo-controlled, crossover study in healthy young men.

Skov-Jeppesen K, Svane MS, Martinussen C, Gabe MBN, Gasbjerg LS, Veedfald S, Bojsen-Møller KN, Madsbad S, Holst JJ, Rosenkilde MM, Hartmann B.

Bone. 2019 Aug;125:178-185. doi: 10.1016/j.bone.2019.05.014. Epub 2019 May 15.

PMID:
31100534
6.

Plasma FGF-19 Levels are Increased in Patients with Post-Bariatric Hypoglycemia.

Mulla CM, Goldfine AB, Dreyfuss JM, Houten S, Pan H, Pober DM, Wewer Albrechtsen NJ, Svane MS, Schmidt JB, Holst JJ, Craig CM, McLaughlin TL, Patti ME.

Obes Surg. 2019 Jul;29(7):2092-2099. doi: 10.1007/s11695-019-03845-0.

PMID:
30976983
7.

Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment.

Schiellerup SP, Skov-Jeppesen K, Windeløv JA, Svane MS, Holst JJ, Hartmann B, Rosenkilde MM.

Front Endocrinol (Lausanne). 2019 Feb 26;10:75. doi: 10.3389/fendo.2019.00075. eCollection 2019. Review.

8.

Augmented GLP-1 Secretion as Seen After Gastric Bypass May Be Obtained by Delaying Carbohydrate Digestion.

Martinussen C, Bojsen-Møller KN, Dirksen C, Svane MS, Kristiansen VB, Hartmann B, Holst JJ, Madsbad S.

J Clin Endocrinol Metab. 2019 Aug 1;104(8):3233-3244. doi: 10.1210/jc.2018-02661.

PMID:
30844053
9.

Postprandial Nutrient Handling and Gastrointestinal Hormone Secretion After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.

Svane MS, Bojsen-Møller KN, Martinussen C, Dirksen C, Madsen JL, Reitelseder S, Holm L, Rehfeld JF, Kristiansen VB, van Hall G, Holst JJ, Madsbad S.

Gastroenterology. 2019 May;156(6):1627-1641.e1. doi: 10.1053/j.gastro.2019.01.262. Epub 2019 Feb 8.

10.

Effect of bariatric surgery on plasma GDF15 in humans.

Kleinert M, Bojsen-Møller KN, Jørgensen NB, Svane MS, Martinussen C, Kiens B, Wojtaszewski JFP, Madsbad S, Richter EA, Clemmensen C.

Am J Physiol Endocrinol Metab. 2019 Apr 1;316(4):E615-E621. doi: 10.1152/ajpendo.00010.2019. Epub 2019 Feb 5.

11.

Mechanisms of action of a carbohydrate-reduced, high-protein diet in reducing the risk of postprandial hypoglycemia after Roux-en-Y gastric bypass surgery.

Kandel D, Bojsen-Møller KN, Svane MS, Samkani A, Astrup A, Holst JJ, Madsbad S, Krarup T.

Am J Clin Nutr. 2019 Aug 1;110(2):296-304. doi: 10.1093/ajcn/nqy310.

PMID:
30624666
12.

[Successful treatment of KCNJ11 neonatal diabetes without insulin].

Gade-Rasmussen B, Madsbad S, Svane MS, Martinussen C, Hansen T.

Ugeskr Laeger. 2018 Nov 12;180(46). pii: V08180547. Danish.

PMID:
30417822
13.

Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss.

Holst JJ, Madsbad S, Bojsen-Møller KN, Svane MS, Jørgensen NB, Dirksen C, Martinussen C.

Surg Obes Relat Dis. 2018 May;14(5):708-714. doi: 10.1016/j.soard.2018.03.003. Epub 2018 Mar 8.

14.

Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production.

Wewer Albrechtsen NJ, Kuhre RE, Hornburg D, Jensen CZ, Hornum M, Dirksen C, Svane M, Gasbjerg LS, Jørgensen NB, Gabe MN, Balk-Møller E, Albrechtsen R, Winther-Sørensen M, Galsgaard KD, Meissner F, Jorsal T, Lund A, Vilsbøll T, Eliasen R, Bojsen-Møller KN, Idorn T, Deacon CF, Knop FK, Rosenkilde MM, Hartmann B, Feldt-Rasmussen B, Mann M, Madsbad S, Holst JJ.

Cell Rep. 2017 Nov 7;21(6):1452-1460. doi: 10.1016/j.celrep.2017.10.034.

15.

Chenodeoxycholic acid stimulates glucagon-like peptide-1 secretion in patients after Roux-en-Y gastric bypass.

Nielsen S, Svane MS, Kuhre RE, Clausen TR, Kristiansen VB, Rehfeld JF, Holst JJ, Madsbad S, Bojsen-Moller KN.

Physiol Rep. 2017 Feb;5(3). pii: e13140. doi: 10.14814/phy2.13140. Epub 2017 Feb 14.

16.

Variable reliability of surrogate measures of insulin sensitivity after Roux-en-Y gastric bypass.

Bojsen-Møller KN, Dirksen C, Svane MS, Jørgensen NB, Holst JJ, Richter EA, Madsbad S.

Am J Physiol Regul Integr Comp Physiol. 2017 May 1;312(5):R797-R805. doi: 10.1152/ajpregu.00291.2016. Epub 2017 Feb 15.

17.

Effect of large weight reductions on measured and estimated kidney function.

von Scholten BJ, Persson F, Svane MS, Hansen TW, Madsbad S, Rossing P.

BMC Nephrol. 2017 Feb 6;18(1):52. doi: 10.1186/s12882-017-0474-0.

18.

Emerging drugs for the treatment of obesity.

Martinussen C, Bojsen-Moller KN, Svane MS, Dejgaard TF, Madsbad S.

Expert Opin Emerg Drugs. 2017 Mar;22(1):87-99. doi: 10.1080/14728214.2017.1269744. Epub 2016 Dec 16. Review.

PMID:
27927032
19.

[Medical therapy versus bariatric surgery of obese patients with Type 2 diabetes].

Svane MS, Bojsen-Møller KN, Madsbad S.

Ugeskr Laeger. 2016 Oct 31;178(44). pii: V06160418. Review. Danish.

PMID:
27808051
20.

No Islet Cell Hyperfunction, but Altered Gut-Islet Regulation and Postprandial Hypoglycemia in Glucose-Tolerant Patients 3 Years After Gastric Bypass Surgery.

Dirksen C, Eiken A, Bojsen-Møller KN, Svane MS, Martinussen C, Jørgensen NB, Holst JJ, Madsbad S.

Obes Surg. 2016 Sep;26(9):2263-2267. doi: 10.1007/s11695-016-2197-x.

PMID:
27138601

Supplemental Content

Loading ...
Support Center